BDNF promotor hypermethylation in the postmortem hippocampus and frontal cortex of AD patients has been reported, supporting observed reductions in BDNF mRNA or protein levels in these brain areas [9,39,40]. The gene discussed is BDNF; the disease is Alzheimer disease.